MiR-145 inhibits cell migration and increases paclitaxel chemosensitivity in prostate cancer cells

OBJECTIVE(S): Prostate cancer (PC) is one of the most commonly diagnosed malignancies among men worldwide. Paclitaxel is a chemotherapeutic agent widely used to treat different types of cancer. Recent studies revealed miRNAs control various genes that influence the regulation of many biological and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tohidast, Maryam, Memari, Neda, Amini, Mohammad, Hosseini, Seyed Samad, Jebelli, Asiyeh, Doustvandi, Mohammad Amin, Baradaran, Behzad, Mokhtarzadeh, Ahad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598815/
https://www.ncbi.nlm.nih.gov/pubmed/37886001
http://dx.doi.org/10.22038/IJBMS.2023.70878.15397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598815/
https://www.ncbi.nlm.nih.gov/pubmed/37886001
http://dx.doi.org/10.22038/IJBMS.2023.70878.15397

Ejemplares similares